1. A novel peptide identified from skin secretions of Bombina maxima possesses LPS-neutralizing activity.
- Author
-
Guo C, Li J, Lee W, Li H, Shen J, and Zhang B
- Subjects
- Animals, Anti-Infective Agents chemistry, Anti-Infective Agents isolation & purification, Anti-Infective Agents pharmacology, Anti-Infective Agents toxicity, Anti-Inflammatory Agents chemistry, Anti-Inflammatory Agents isolation & purification, Anti-Inflammatory Agents pharmacology, Anti-Inflammatory Agents toxicity, Cytokines biosynthesis, Cytokines genetics, Cytokines immunology, Drug Evaluation, Preclinical, Hemolysis drug effects, Humans, Lipopolysaccharides immunology, Male, Mice, Microbial Sensitivity Tests, Molecular Docking Simulation, Peptides toxicity, Protein Binding, RAW 264.7 Cells, RNA, Messenger genetics, Survival Rate, Anura metabolism, Lipopolysaccharides antagonists & inhibitors, Peptides isolation & purification, Peptides pharmacology, Sepsis drug therapy, Skin chemistry, Skin metabolism
- Abstract
Lipopolysaccharide (LPS) is a major pathogenic factor in endotoxin shock or sepsis. Most antibiotics have little clinical anti-endotoxin activity, but some antimicrobial peptides (AMPs) have been shown to be effective in blocking LPS. We identified a novel peptide from the skin secretions of Bombina maxima (B. _maxima) by challenging the skin of frogs with an LPS solution. Peptide 2 has an amino acid sequence of LVGKLLKGAVGDVCGLLPIC. Peptide 2 possesses low hemolytic activity, low cytotoxicity against RAW 264.7 cells, and strong anti-inflammatory activity. Moreover, peptide 2 plays an anti-inflammatory role by inhibiting inflammatory cytokines such as tumor necrosis factor alpha (TNF-α) and interleukin-6 (IL-6). A biolayer interferometry (BLI) assay indicated that peptide 2 binds to LPS with strong affinity and that this interaction has an affinity constant (K
D ) value of 1.05 × 10-9 M. A survival study showed that peptide 2 possesses potent LPS-neutralizing activity to protect LPS-treated mice from death. In conclusion, we have identified a potent peptide with LPS neutralizing activity, which lays a foundation for future research and development., Competing Interests: Declaration of competing interest The authors declare no conflict of interest., (Copyright © 2021 Elsevier Inc. All rights reserved.)- Published
- 2021
- Full Text
- View/download PDF